ATNM Earnings

Quarterly EPS
$-0.37
Q3 2024
$-0.21
Q4 2024
$-0.51
Q1 2025
$-0.22
Q2 2025
$-0.16
Q3 2025
$-0.19
Q4 2025
$-0.18
Q1 2026
$0.89
Q2 2026
Latest Revenue35.0M
Latest Net Income27.9M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.8935.0M27.9M—+504.5%
Q1 2026-$0.180-5522000—+64.7%
Q4 2025-$0.190-5940000—+9.5%
Q3 2025-$0.1690.0K-5131000—+56.8%
Q2 2025-$0.220-6878000—+42.1%
Q1 2025-$0.510-15938000—-64.5%
Q4 2024-$0.210-6652000-100.0%+38.2%
Q3 2024-$0.370-11568000—+24.5%
Q2 2024-$0.380-11353000——
Q1 2024-$0.310-8670000——
Q4 2023-$0.3481.0K-9324000——
Q3 2023-$0.490-13276000——
Actinium Pharmaceuticals (ATNM) — Earnings